A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1998
11/12/1998	WO1998050062A1 Compositions and methods of therapy for igf-i-responsive conditions
11/12/1998	WO1998050060A1 Therapies for acute renal failure
11/12/1998	WO1998050057A2 Agent for enhancing the heart force
11/12/1998	WO1998050050A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
11/12/1998	WO1998050038A1 Use of quinazoline compounds for the treatment of polycystic kidney disease
11/12/1998	WO1998050034A1 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells
11/12/1998	WO1998050033A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998	WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998	WO1998050031A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050030A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050029A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998	WO1998050016A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/12/1998	WO1998049972A2 Differential treatment of prosthetic devices
11/12/1998	WO1998049897A1 Beta lactams as antiproliferative agents
11/12/1998	WO1998035951A3 New aminopiperazine derivatives
11/12/1998	WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998	CA2289705A1 Beta lactams as antiproliferative agents
11/12/1998	CA2289602A1 Protease inhibitors
11/12/1998	CA2289123A1 Therapies for acute renal failure
11/12/1998	CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998	CA2289108A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998	CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	CA2289096A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alpha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998	CA2289094A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	CA2289025A1 Human serine protease precursor
11/12/1998	CA2289011A1 B-ring estratriene diol sulphates
11/12/1998	CA2289010A1 Protease inhibitors
11/12/1998	CA2289008A1 Estrenes
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/12/1998	CA2288999A1 B-ring estratrienes
11/12/1998	CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998	CA2288901A1 Uncoupling protein homologue: ucp 3
11/12/1998	CA2288899A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998	CA2288778A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
11/12/1998	CA2288759A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998	CA2288662A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998	CA2288333A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998	CA2288330A1 Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
11/12/1998	CA2288232A1 Immunotoxins directed against malignant cells
11/12/1998	CA2287999A1 Compounds
11/12/1998	CA2287929A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998	CA2287924A1 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase
11/12/1998	CA2287913A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998	CA2287569A1 Serine protease inhibitors
11/12/1998	CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998	CA2285419A1 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells
11/11/1998	EP0877089A1 HMG-CoA reductase inhibitor preparation process
11/11/1998	EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998	EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998	EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998	EP0876487A1 Mammalian cx 3?c chemokine genes
11/11/1998	EP0876485A2 NOVEL CREBa ISOFORM
11/11/1998	EP0876482A1 Il-13 receptor polypeptide
11/11/1998	EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX
11/11/1998	EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998	EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors
11/11/1998	EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998	EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998	EP0876371A1 Reverse-turn mimetics and methods relating thereto
11/11/1998	EP0876365A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
11/11/1998	EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998	EP0876350A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
11/11/1998	EP0876348A1 Salts of quinoline derivatives as nk3 antagonists
11/11/1998	EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998	EP0876336A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases
11/11/1998	EP0876330A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
11/11/1998	EP0876160A2 Ligand directed enzyme prodrug therapy
11/11/1998	EP0876154A1 Using serine-proteases for acne and inflamed comedones
11/11/1998	EP0876153A2 Medical use of proteases
11/11/1998	EP0876149A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
11/11/1998	EP0876143A2 TUMOR NECROSIS FACTOR ALPHA (TNF-$g(a)) INHIBITING PHARMACEUTICALS
11/11/1998	EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998	EP0796080B1 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
11/11/1998	EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
11/11/1998	EP0717742B1 Process for the preparation of indolizine derivatives
11/11/1998	EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers
11/11/1998	CN1198776A Novel DNAS and process for producing proteins by using the same
11/11/1998	CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998	CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998	CN1198739A (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanolmethanesulfonate trihydrate
11/11/1998	CN1198335A Hand liniment
11/11/1998	CN1040646C Enatiomeric hydroxylated xanthine compound
11/11/1998	CN1040645C Compound with 5-HT4 receptor rivalry activity, its preparation and pharmaceutical composition containing said compound
11/10/1998	US5834594 Polyethylene-protein conjugates
11/10/1998	US5834519 Stabilized gas-supersaturated emulsions and suspensions
11/10/1998	US5834508 Ketone derivatives
11/10/1998	US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998	US5834500 Administering derivatives of benzyloxy-benzothiazenes to control release of prostaglandins, leukotrienes, histamines, tachykinins, thromboxanes; analgesics, antiasthmatic, antiinflammatory, wound healing and antitumor agentsagents
11/10/1998	US5834494 Pyridylcarbamoyl Indolines
11/10/1998	US5834485 Quinoline sulfonamides and their therapeutic use
11/10/1998	US5834483 Method of treating heart failure with endothelin antagonists
11/10/1998	US5834481 Hypotensive agents
11/10/1998	US5834478 Morphinan hydroxamic acid compounds
11/10/1998	US5834471 Amide derivatives as 5HT1D receptor antagonists
11/10/1998	US5834468 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
11/10/1998	US5834467 HIV protease inhibitors
11/10/1998	US5834451 Remedy for myotonic dystrophy
11/10/1998	US5834432 Use of angiotensin II Type 2 receptor agonists in tissue repair
11/10/1998	US5834420 Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation

1 ... 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 ... 1564